VRNA

Verona Pharma

10 hedge funds and large institutions have $81M invested in Verona Pharma in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
3
Increased
2
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
VC
1
Vivo Capital
California
$22.9M 1,492,951 +788,726 +112%
NMC
2
NEA Management Company
Maryland
$18.7M 1,219,674 +553,008 +83%
NHAS
3
Novo Holdings A/S
Denmark
$11.4M 740,740
O
4
OrbiMed
New York
$10.2M 666,666
FCMI
5
Foresite Capital Management III
California
$9.35M 608,851 -4,750 -0.8%
TCM
6
Tekla Capital Management
Massachusetts
$4.22M 275,000
PA
7
Perceptive Advisors
New York
$3.07M 200,000
PC
8
Polar Capital
United Kingdom
$1.17M 75,917 +75,917 New
TRCT
9
Tower Research Capital (TRC)
New York
$3K 199 +199 New
Fidelity International
10
Fidelity International
Bermuda
-75,813 Closed
Jane Street
11
Jane Street
New York
-11,444 Closed
Morgan Stanley
12
Morgan Stanley
New York
$0 14 +14 New